Track the 昭衍新药 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 昭衍新药 has published 44 public disclosures. Market capitalisation: €33.9bn. The latest transaction was disclosed on 30 September 2025 (Sale). Among the most active insiders: 左从林. All data is accessible without an account.
44
Insider Decl.
n/a
Thresholds
€94,205
1 ops.
Buy Volume
€191m
43 ops.
Sell Volume
22Σ signal
Buys €94,205€191m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,472 of 28,717 companies
51.8
score / 100
Value
41
Quality
63
FCF yld0.9%
Earn yld0.9%
EV/EBITDA·
ROE5.9%
Gross mgn21%
Net mgn18%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
